The Home-Based Telemental Health Care Act of 2025 would authorize federal grants to expand mental health and substance use services for rural underserved populations and workers in farming, fishing, or forestry occupations. Grant recipients must deliver care via telehealth directly in patients' homes or comfortable settings, measure its effectiveness compared to in-person care, and improve infrastructure like broadband access and patient devices. The program requires annual reports on outcomes after three years and every two years, with up to $10 million allocated yearly from 2025 through 2029. This initiative aims to address geographic and occupational barriers to mental health care access.
This bill prevents employers from dropping health insurance coverage for workers during strikes or lockouts. It amends the National Labor Relations Act to prohibit employers from terminating group health plan coverage for employees who are either locked out (during bargaining disputes) or participating in a lawful strike. Employers who violate this rule face civil penalties of up to $75,000 per violation for lockout-related actions (doubling to $150,000 for repeat offenses) or $50,000 for strike-related actions (doubling to $100,000 for repeat offenses). The law directly affects workers engaged in strikes or locked out by employers, ensuring their healthcare coverage continues during these labor disputes.
The POP Act (HR 5433) prohibits any entity from owning both a Medicare-focused health insurance company and certain healthcare providers (like clinics or outpatient facilities, excluding hospitals, pharmacies, and durable medical equipment suppliers). It requires violators to divest one business within 1-2 years of the law's enactment or acquisition. The Federal Trade Commission and state attorneys general can enforce this through civil actions, including ordering divestment and recovering revenue from violations. The law also updates Medicare rules to ban such ownership for Medicare Advantage plans starting in 2026, treating violations as false claims. This directly affects health insurers and provider networks operating under Medicare.
The End Price Gouging for Medications Act establishes annual reference prices for prescription drugs based on the lowest retail prices in 12 international reference countries (like Canada and the UK) or specific criteria if international data is unavailable. It requires drug manufacturers to sell medications at or below these reference prices for all patients covered by federal health programs - including Medicare, Medicaid, TRICARE, and VA care - as well as for all other patients, including those with private insurance. Manufacturers violating this rule face civil penalties of five times the revenue difference, with collected funds directed to the National Institutes of Health for drug research. This bill directly affects drug manufacturers and millions of Americans enrolled in the specified federal health programs.
This non-binding Senate resolution (SRES 389) condemns Secretary of Health and Human Services Robert F. Kennedy, Jr.'s actions dismissing the CDC's independent Advisory Committee on Immunization Practices and opposes Florida's 2025 policy rolling back school immunization requirements for children. It affirms that vaccines are critical for public health, preventable illness, and hospitalization reduction, and must be widely accessible at high community adoption rates. The resolution expresses the Senate's support for science-based vaccine policies, opposes politicizing medical recommendations, and emphasizes that vaccines should remain affordable and available through insurance and community settings like clinics and pharmacies. It does not create new laws but formally states the Senate's position against policies it views as endangering public health.
SRES 67 is a Senate resolution declaring racism a public health crisis in the United States. It cites documented racial health disparities - including lower life expectancy, higher maternal mortality, and disproportionate disease burdens among Black, American Indian, Alaska Native, and other minority communities - as meeting public health crisis criteria (affecting many, unfairly distributed, preventable, and lacking current solutions). The resolution calls for a nationwide strategy to dismantle systemic racism and address social determinants of health (like housing, education, and healthcare access), but it does not create new laws or funding. As a symbolic resolution, it aims to prompt government action rather than impose policy changes.
House Resolution 388 designates the first week of April as "Adolescent Immunization Action Week" to promote vaccination for teens and young adults. The resolution calls on communities, health providers, and organizations to support immunization efforts, particularly addressing vaccine misinformation and low uptake in rural and underserved areas. It does not create new laws or funding but encourages collaborative action to improve vaccination rates for adolescents.
This bill requires Medicare to cover lung cancer biomarker testing for beneficiaries diagnosed with lung cancer, starting January 1, 2027. It defines the testing as procedures analyzing tissue, blood, or bodily fluids to identify specific biomarkers (like genes or proteins) for treatment planning. Medicare will pay 100% of reasonable charges for these tests, removing out-of-pocket costs for patients. The policy directly affects Medicare patients with lung cancer who need this specialized testing to guide personalized treatment options.
This resolution expresses the U.S. House of Representatives' support for recognizing October 26, 2025, as Intersex Awareness Day, which honors intersex individuals - those with natural variations in physical sex characteristics (such as anatomy, hormones, or chromosomes) that differ from typical male or female bodies. It affirms the day’s goals of promoting bodily autonomy and addressing issues like nonconsensual medical procedures on intersex children. The resolution encourages federal agencies, schools, and organizations to observe the day through educational activities that increase public awareness and support for the intersex community. It does not create new laws or policies but symbolically aligns with existing federal actions promoting nondiscrimination and health equity for intersex people.
The Health Investment Zones Act of 2026 creates a program to designate areas with significant health disparities as "Health Investment Zones" to improve health outcomes. The bill provides tax incentives including a new 30% tax credit for wages paid to qualified Health Investment Zone workers and incentive payments for Medicare services provided in these zones. It also establishes a grant program for community organizations to fund health care improvements and a student loan repayment program for health care practitioners working in designated zones. Areas must meet specific criteria related to income levels, health outcomes, and documented health disparities to qualify for designation, with zones designated for 10 years.
